TAX incentives for researchers are making clinical trials in Australia up to 60% more cost-effective, according to a new report by Frost & Sullivan, which estimates the clinical trials market is growing at an annual rate of 12% and will be valued at $615m by 2019.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Oct 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Oct 16
